Skip to content

Clinical trials

Phase 3 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 3 Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20021
20037
20043
200510
20067
20072
20087
20095
201011
201114
20122
20135
20149
20157
20166
20172
20189
20198
20204
20216
20225
20231
20241
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131
Recruiting8
Withdrawn7
Terminated6
Unknown status4
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research42
Allergan18
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.10
Santen Pharmaceutical Co., Ltd.10
Aerie Pharmaceuticals8
Santen Oy5
AbbVie4
Bausch & Lomb Incorporated4
Glaukos Corporation4
Merck Sharp & Dohme LLC4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension158
Glaucoma, Open-Angle117
Glaucoma65
Hypertension9
Cataract2
Exfoliation Syndrome1
Eye Diseases1
Glaucoma, Angle-Closure1

Trials

Showing 26 to 50 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.